Cargando…
CD5: from antiquated T cell marker to immunotherapy’s new hope
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212910/ https://www.ncbi.nlm.nih.gov/pubmed/37230972 http://dx.doi.org/10.1038/s41392-023-01494-5 |
| _version_ | 1785047515249246208 |
|---|---|
| author | Schwarz, Sandra Linnebacher, Michael |
| author_facet | Schwarz, Sandra Linnebacher, Michael |
| author_sort | Schwarz, Sandra |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10212910 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102129102023-05-27 CD5: from antiquated T cell marker to immunotherapy’s new hope Schwarz, Sandra Linnebacher, Michael Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2023-05-25 /pmc/articles/PMC10212910/ /pubmed/37230972 http://dx.doi.org/10.1038/s41392-023-01494-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Research Highlight Schwarz, Sandra Linnebacher, Michael CD5: from antiquated T cell marker to immunotherapy’s new hope |
| title | CD5: from antiquated T cell marker to immunotherapy’s new hope |
| title_full | CD5: from antiquated T cell marker to immunotherapy’s new hope |
| title_fullStr | CD5: from antiquated T cell marker to immunotherapy’s new hope |
| title_full_unstemmed | CD5: from antiquated T cell marker to immunotherapy’s new hope |
| title_short | CD5: from antiquated T cell marker to immunotherapy’s new hope |
| title_sort | cd5: from antiquated t cell marker to immunotherapy’s new hope |
| topic | Research Highlight |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212910/ https://www.ncbi.nlm.nih.gov/pubmed/37230972 http://dx.doi.org/10.1038/s41392-023-01494-5 |
| work_keys_str_mv | AT schwarzsandra cd5fromantiquatedtcellmarkertoimmunotherapysnewhope AT linnebachermichael cd5fromantiquatedtcellmarkertoimmunotherapysnewhope |